From the Journals

Post–COVID-19 cardiac involvement in college athletes much rarer than thought


 

FROM CIRCULATION

Limit CMR to symptomatic athletes

“I think this data can be extended beyond the college athlete. And it’s fair to say to high school athletes and young recreational athletes who have had asymptomatic or mild infection, you probably don’t need further workup if you’re feeling fine,” suggested Dr. Harmon.

“For those with moderate or severe illness, then the triple screen protocol is a good idea, particularly if they are having any symptoms,” she added.

Dr. Lander agrees that athletes should be screened by appropriate providers before returning to sports, but that CMR should not be used routinely for return-to-play screening.

“We’ve never taken a group of, say, 1,000 college athletes who just recovered from the flu and done cardiac MRIs on them, so it’s a bit like opening Pandora’s box when it’s used too liberally. It’s difficult to assess if the findings are secondary to COVID infection or from something entirely unrelated,” he noted.

ORCCA is a collaboration of the American Heart Association and the American Medical Society for Sports Medicine to track COVID-19 cases among National Collegiate Athletic Association (NCAA) athletes. The current study was supported by a grant from the American Medical Society for Sports Medicine.

Pages

Recommended Reading

New return-to-play recommendations for athletes with COVID-19
Covid ICYMI
Myocarditis rare, macrophage infiltration common at COVID autopsy
Covid ICYMI
Infant’s COVID-19–related myocardial injury reversed
Covid ICYMI
COVID-19 and risk of clotting: ‘Be proactive about prevention’
Covid ICYMI
COVID-19 case fatality doubled in heart transplant patients
Covid ICYMI
COVID-19 mortality in hospitalized HF patients: Nearly 1 in 4
Covid ICYMI
Myocarditis by CMR may be rare after COVID-19 in elite athletes
Covid ICYMI
Inpatient sodium imbalances linked to adverse COVID-19 outcomes
Covid ICYMI
Remote cardio visits expand access for underserved during COVID
Covid ICYMI
Pneumonia risk soars in heart failure patients, especially HFpEF
Covid ICYMI